Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 409

    1.

    Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.

    Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A.

    Diabetes Care. 2005 Apr;28(4):950-5.PMID: 15793205 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin glargine: a systematic review of a long-acting insulin analogue.

    Wang F, Carabino JM, Vergara CM.

    Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.PMID: 12860485 [PubMed - indexed for MEDLINE]Related articles

    3.

    Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

    Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB.

    Diabetes Care. 2001 Apr;24(4):631-6.PMID: 11315821 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

    Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators.

    Diabetes Care. 2003 Nov;26(11):3080-6.PMID: 14578243 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients.

    Pan CY, Sinnassamy P, Chung KD, Kim KW; LEAD Study Investigators Group.

    Diabetes Res Clin Pract. 2007 Apr;76(1):111-8. Epub 2006 Oct 2.PMID: 17011662 [PubMed - indexed for MEDLINE]Related articles

    9.

    Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride.

    Eliaschewitz FG, Calvo C, Valbuena H, Ruiz M, Aschner P, Villena J, Ramirez LA, Jimenez J; HOE 901/4013 LA Study Group.

    Arch Med Res. 2006 May;37(4):495-501.PMID: 16715577 [PubMed - indexed for MEDLINE]Related articles

    10.

    A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

    Raskin P, Klaff L, Bergenstal R, Hallé JP, Donley D, Mecca T.

    Diabetes Care. 2000 Nov;23(11):1666-71.PMID: 11092290 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Dosing of insulin glargine in the treatment of type 2 diabetes.

    Barnett A.

    Clin Ther. 2007 Jun;29(6):987-99. Review.PMID: 17692716 [PubMed - indexed for MEDLINE]Related articles

    12.

    Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).

    Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T.

    Endocr J. 2007;54(6):975-83. Epub 2007 Nov 14.PMID: 18000343 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes.

    Massi Benedetti M, Humburg E, Dressler A, Ziemen M.

    Horm Metab Res. 2003 Mar;35(3):189-96.PMID: 12734781 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.

    Duckworth W, Davis SN.

    J Diabetes Complications. 2007 May-Jun;21(3):196-204. Review.PMID: 17493554 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.

    Fulcher GR, Gilbert RE, Yue DK.

    Intern Med J. 2005 Sep;35(9):536-42.PMID: 16105155 [PubMed - indexed for MEDLINE]Related articles

    16.

    Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

    Rosenstock J, Park G, Zimmerman J; U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.

    Diabetes Care. 2000 Aug;23(8):1137-42.PMID: 10937511 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.

    Dailey G, Strange P.

    Am J Manag Care. 2008 Jan;14(1):25-30.PMID: 18197742 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.

    McKeage K, Goa KL.

    Treat Endocrinol. 2002;1(1):55-8. Review.PMID: 15765621 [PubMed - indexed for MEDLINE]Related articles

    20.

    Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

    Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

    Clin Ther. 2008 Aug;30(8):1476-84.PMID: 18803989 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data